Search
for
Sort by
Research 30 of 256
- Human Dermal Safety Studies with Eflornithine HCl 13.9% Cream (Vaniqa™), a Novel Treatment for Excessive Facial Hair
- Excess salt and pepper hair treated with a combination of laser hair removal and topical eflornithine HCl.
- Randomized, double‐blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair
- Vaniqa--eflornithine 13.9% cream.
- Hair disorders update: Alopecia to hirsutism
- Targeting hirsutism: a new approach*1
- A method to improve the efficacy of topical eflornithine hydrochloride cream
- TOPICAL EFLORNITHINE TREATMENT FOR HIRSUTISM IN WOMEN: SUMMARY OF FINDINGS
- A randomized study of eflornithine cream combined with intense pulsed light versus intense pulsed light treatment alone for hirsutism in women
- Therapeutic options in the polycystic ovary syndrome
- Idiopathic hirsutism: excessive bodily and facial hair in women
- Diagnosis and treatments of hirsutism: where are we?
- Eflornithine Hydrochloride-Loaded Electrospun Nanofibers as a Potential Face Mask for Hirsutism Application
- Treatment of hyperandrogenism in polycystic ovary syndrome
- Treatments for unwanted facial hair.
- Hirsutism and Hypertrichosis
- Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- Polycystic Ovary Syndrome
- Understanding and Addressing Hair Disorders in Transgender Individuals
- Management of Facial Hair in Women
- Dermatologic care of the transgender patient - eScholarship
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Capryloyl glycine and soy isoflavonoids in hypertrichosis: An experimental and placebo‐controlled clinical study
- Spermidine Promotes Human Hair Growth and Is a Novel Modulator of Human Epithelial Stem Cell Functions
- Treatment options for polycystic ovary syndrome
- The pathogenesis and treatment of polycystic ovary syndrome: What’s new?
- Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/– mice
- Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/– mice
- Anticancer agents against malaria: time to revisit?